Can we use HCC risk scores to individualize surveillance in chronic hepatitis B infection?

Journal of Hepatology

Volumn 63, Issue 3, 2015, Pages 722-732

  Wong, Vincent Wai Sun ^a   Janssen, Harry L A ^b,c  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b TORONTO WESTERN HOSPITAL   (Canada)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Cirrhosis; HBV DNA; Hepatitis B virus; Hepatocellular carcinoma; Transient elastography

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; BILIRUBIN; ENTECAVIR; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; MOLECULAR MARKER; NUCLEOSIDE ANALOG; PEGINTERFERON; TENOFOVIR; TENOFOVIR DISOPROXIL; VIRUS DNA;

ANTIVIRAL THERAPY; ARTICLE; CANCER RISK; CHINESE UNIVERSITY HEPATOCELLULAR CARCINOMA SCORE; CHRONIC HEPATITIS B; CLINICAL PRACTICE; DIGESTIVE SYSTEM DISEASE ASSESSMENT; DISEASE SURVEILLANCE; ELASTOGRAPHY; ETHNIC GROUP; GAG HEPATOCELLULAR CARCINOMA SCORE; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FIBROSIS; NON INVASIVE PROCEDURE; PREDICTIVE VALUE; PRIORITY JOURNAL; RISK ESTIMATION FOR HEPATOCELLULAR CARCINOMA IN CHRONIC HEPATITIS B SCORE; SCORING SYSTEM; CARCINOMA, HEPATOCELLULAR; COMPLICATION; GENETICS; GENOTYPE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; LIVER NEOPLASMS; RISK;

CARCINOMA, HEPATOCELLULAR; DNA, VIRAL; GENOTYPE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LIVER NEOPLASMS; RISK;

EID: 84939255393     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2015.05.019     Document Type: Review

References (97)

1. C. Trepo, H.L. Chan, and A. Lok Hepatitis B virus infection Lancet 384 2014 2053 2063
2. C.J. Chiang, Y.W. Yang, S.L. You, M.S. Lai, and C.J. Chen Thirty-year outcomes of the national hepatitis B immunization program in Taiwan JAMA 310 2013 974 976
3. Y.F. Liaw, J.J. Sung, W.C. Chow, G. Farrell, C.Z. Lee, H. Yuen, and et al. Lamivudine for patients with chronic hepatitis B and advanced liver disease N Engl J Med 351 2004 1521 1531
4. T. Hosaka, F. Suzuki, M. Kobayashi, Y. Seko, Y. Kawamura, H. Sezaki, and et al. Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection Hepatology 58 2013 98 107
5. G.L. Wong, H.L. Chan, C.W. Mak, S.K. Lee, Z.M. Ip, A.T. Lam, and et al. Entecavir treatment reduces hepatic events and deaths in chronic hepatitis B patients with liver cirrhosis Hepatology 58 2013 1537 1547
6. J. Bruix, G.J. Gores, and V. Mazzaferro Hepatocellular carcinoma: clinical frontiers and perspectives Gut 63 2014 844 855
7. J.S. Wong, G.L. Wong, K.K. Tsoi, V.W. Wong, S.Y. Cheung, C.N. Chong, and et al. Meta-analysis: the efficacy of anti-viral therapy in prevention of recurrence after curative treatment of chronic hepatitis B-related hepatocellular carcinoma Aliment Pharmacol Ther 33 2011 1104 1112
8. C.Y. Wu, Y.J. Chen, H.J. Ho, Y.C. Hsu, K.N. Kuo, M.S. Wu, and et al. Association between nucleoside analogues and risk of hepatitis B virus-related hepatocellular carcinoma recurrence following liver resection JAMA 308 2012 1906 1914
9. C.C. Chong, G.L. Wong, V.W. Wong, P.C. Ip, Y.S. Cheung, J. Wong, and et al. Antiviral therapy improves post-hepatectomy survival in patients with hepatitis B virus-related hepatocellular carcinoma: a prospective-retrospective study Aliment Pharmacol Ther 41 2015 199 208
10. K. Nouso, H. Tanaka, S. Uematsu, K. Shiraga, R. Okamoto, H. Onishi, and et al. Cost-effectiveness of the surveillance program of hepatocellular carcinoma depends on the medical circumstances J Gastroenterol Hepatol 23 2008 437 444
11. G.V. Papatheodoridis, H.L. Chan, B.E. Hansen, H.L. Janssen, and P. Lampertico Risk of hepatocellular carcinoma in chronic hepatitis B: assessment and modification with current antiviral therapy J Hepatol 62 2015 956 967
12. G. Fattovich, F. Bortolotti, and F. Donato Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors J Hepatol 48 2008 335 352
13. Y.F. Liaw, D.I. Tai, C.M. Chu, D.Y. Lin, I.S. Sheen, T.J. Chen, and et al. Early detection of hepatocellular carcinoma in patients with chronic type B hepatitis. A prospective study Gastroenterology 90 1986 263 267
14. M.F. Yuen, H.J. Yuan, D.K. Wong, J.C. Yuen, W.M. Wong, A.O. Chan, and et al. Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications Gut 54 2005 1610 1614
15. H.B. El-Serag, and K.L. Rudolph Hepatocellular carcinoma: epidemiology and molecular carcinogenesis Gastroenterology 132 2007 2557 2576
16. W.E. Naugler, T. Sakurai, S. Kim, S. Maeda, K. Kim, A.M. Elsharkawy, and et al. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production Science 317 2007 121 124
17. H. Feng, A.S. Cheng, D.P. Tsang, M.S. Li, M.Y. Go, Y.S. Cheung, and et al. Cell cycle-related kinase is a direct androgen receptor-regulated gene that drives beta-catenin/T cell factor-dependent hepatocarcinogenesis J Clin Invest 121 2011 3159 3175
18. E. Fernandez, C. La Vecchia, B. D'Avanzo, E. Negri, and S. Franceschi Family history and the risk of liver, gallbladder, and pancreatic cancer Cancer Epidemiol Biomarkers Prev 3 1994 209 212
19. M.W. Yu, H.C. Chang, Y.F. Liaw, S.M. Lin, S.D. Lee, C.J. Liu, and et al. Familial risk of hepatocellular carcinoma among chronic hepatitis B carriers and their relatives J Natl Cancer Inst 92 2000 1159 1164
20. R. Loomba, J. Liu, H.I. Yang, M.H. Lee, S.N. Lu, L.Y. Wang, and et al. Synergistic effects of family history of hepatocellular carcinoma and hepatitis B virus infection on risk for incident hepatocellular carcinoma Clin Gastroenterol Hepatol 11 2013 e1631 e1633
21. P. Nahon, and J. Zucman-Rossi Single nucleotide polymorphisms and risk of hepatocellular carcinoma in cirrhosis J Hepatol 57 2012 663 674
22. W.K. Sung, H. Zheng, S. Li, R. Chen, X. Liu, Y. Li, and et al. Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma Nat Genet 44 2012 765 769
23. K.C. Chan, P. Jiang, C.W. Chan, K. Sun, J. Wong, E.P. Hui, and et al. Noninvasive detection of cancer-associated genome-wide hypomethylation and copy number aberrations by plasma DNA bisulfite sequencing Proc Natl Acad Sci U S A 110 2013 18761 18768
24. C.L. Chen, H.I. Yang, W.S. Yang, C.J. Liu, P.J. Chen, S.L. You, and et al. Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan Gastroenterology 135 2008 111 121
25. M.W. Yu, W.L. Shih, C.L. Lin, C.J. Liu, J.W. Jian, K.S. Tsai, and et al. Body-mass index and progression of hepatitis B: a population-based cohort study in men J Clin Oncol 26 2008 5576 5582
26. G.L. Wong, V.W. Wong, P.C. Choi, A.W. Chan, A.M. Chim, K.K. Yiu, and et al. Metabolic syndrome increases the risk of liver cirrhosis in chronic hepatitis B Gut 58 2009 111 117
27. P. Marcellin, E. Gane, M. Buti, N. Afdhal, W. Sievert, I.M. Jacobson, and et al. Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study Lancet 381 2013 468 475
28. V.W. Wong, G.L. Wong, W.C. Chu, A.M. Chim, A. Ong, D.K. Yeung, and et al. Hepatitis B virus infection and fatty liver in the general population J Hepatol 56 2012 533 540
29. H.I. Yang, S.N. Lu, Y.F. Liaw, S.L. You, C.A. Sun, L.Y. Wang, and et al. Hepatitis B e antigen and the risk of hepatocellular carcinoma N Engl J Med 347 2002 168 174
30. C.J. Chen, H.I. Yang, J. Su, C.L. Jen, S.L. You, S.N. Lu, and et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level JAMA 295 2006 65 73
31. T. Andreani, L. Serfaty, D. Mohand, S. Dernaika, D. Wendum, O. Chazouilleres, and et al. Chronic hepatitis B virus carriers in the immunotolerant phase of infection: histologic findings and outcome Clin Gastroenterol Hepatol 5 2007 636 641
32. V.W. Wong, and J.J. Sung Diagnosis and personalized management of hepatitis B including significance of genotypes Curr Opin Infect Dis 25 2012 570 577
33. C.J. Chu, M. Hussain, and A.S. Lok Hepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus genotype C Gastroenterology 122 2002 1756 1762
34. H.L. Chan, G.L. Wong, C.H. Tse, A.M. Chim, K.K. Yiu, H.Y. Chan, and et al. Hepatitis B virus genotype C is associated with more severe liver fibrosis than genotype B Clin Gastroenterol Hepatol 7 2009 1361 1366
35. H.L. Chan, A.Y. Hui, M.L. Wong, A.M. Tse, L.C. Hung, V.W. Wong, and et al. Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma Gut 53 2004 1494 1498
36. M.W. Yu, S.H. Yeh, P.J. Chen, Y.F. Liaw, C.L. Lin, C.J. Liu, and et al. Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men J Natl Cancer Inst 97 2005 265 272
37. H.I. Yang, S.H. Yeh, P.J. Chen, U.H. Iloeje, C.L. Jen, J. Su, and et al. Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma J Natl Cancer Inst 100 2008 1134 1143
38. G.L. Wong, H.L. Chan, K.K. Yiu, J.W. Lai, V.K. Chan, K.K. Cheung, and et al. Meta-analysis: the association of hepatitis B virus genotypes and hepatocellular carcinoma Aliment Pharmacol Ther 37 2013 517 526
39. J.H. Kao, P.J. Chen, M.Y. Lai, and D.S. Chen Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers Gastroenterology 124 2003 327 334
40. M. Baptista, A. Kramvis, and M.C. Kew High prevalence of 1762(T) 1764(A) mutations in the basic core promoter of hepatitis B virus isolated from black Africans with hepatocellular carcinoma compared with asymptomatic carriers Hepatology 29 1999 946 953
41. T.C. Tseng, C.J. Liu, H.C. Yang, C.L. Chen, W.T. Yang, C.S. Tsai, and et al. Higher proportion of viral basal core promoter mutant increases the risk of liver cirrhosis in hepatitis B carriers Gut 64 2015 292 302
42. H.L. Chan, A. Thompson, M. Martinot-Peignoux, T. Piratvisuth, M. Cornberg, M.R. Brunetto, and et al. Hepatitis B surface antigen quantification: why and how to use it in 2011 - A core group report J Hepatol 55 2011 1121 1131
43. T.C. Tseng, C.J. Liu, H.C. Yang, T.H. Su, C.C. Wang, C.L. Chen, and et al. High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load Gastroenterology 142 2012 1140 1149 e1143; quiz e1113-1144
44. G. Fattovich, G. Giustina, E. Christensen, M. Pantalena, I. Zagni, G. Realdi, and et al. Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B. The European Concerted Action on Viral Hepatitis (Eurohep) Gut 46 2000 420 426
45. C.L. Thio, E.C. Seaberg, R. Skolasky Jr., J. Phair, B. Visscher, A. Munoz, and et al. HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS) Lancet 360 2002 1921 1926
46. M. Bonacini, S. Louie, N. Bzowej, and A.R. Wohl Survival in patients with HIV infection and viral hepatitis B or C: a cohort study AIDS 18 2004 2039 2045
47. J.P. Zarski, B. Bohn, A. Bastie, J.M. Pawlotsky, M. Baud, F. Bost-Bezeaux, and et al. Characteristics of patients with dual infection by hepatitis B and C viruses J Hepatol 28 1998 27 33
48. C.J. Liu, Y.T. Chu, W.Y. Shau, R.N. Kuo, P.J. Chen, and M.S. Lai Treatment of patients with dual hepatitis C and B by peginterferon alpha and ribavirin reduced risk of hepatocellular carcinoma and mortality Gut 63 2014 506 514
49. J. Bruix, M. Sherman American Association for the Study of Liver Diseases Management of hepatocellular carcinoma: an update Hepatology 53 2011 1020 1022
50. M. Omata, L.A. Lesmana, R. Tateishi, P.J. Chen, S.M. Lin, H. Yoshida, and et al. Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma Hepatol Int 4 2010 439 474
51. European Association for the Study of the Liver European Organisation for Research and Treatment of Cancer EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma J Hepatol 56 2012 908 943
52. M.F. Yuen, Y. Tanaka, D.Y. Fong, J. Fung, D.K. Wong, J.C. Yuen, and et al. Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B J Hepatol 50 2009 80 88
53. T.S. Mok, W. Yeo, S. Yu, P. Lai, H.L. Chan, A.T. Chan, and et al. An intensive surveillance program detected a high incidence of hepatocellular carcinoma among hepatitis B virus carriers with abnormal alpha-fetoprotein levels or abdominal ultrasonography results J Clin Oncol 23 2005 8041 8047
54. V.W. Wong, S.L. Chan, F. Mo, T.C. Chan, H.H. Loong, G.L. Wong, and et al. Clinical scoring system to predict hepatocellular carcinoma in chronic hepatitis B carriers J Clin Oncol 28 2010 1660 1665
55. H.I. Yang, M. Sherman, J. Su, P.J. Chen, Y.F. Liaw, U.H. Iloeje, and et al. Nomograms for risk of hepatocellular carcinoma in patients with chronic hepatitis B virus infection J Clin Oncol 28 2010 2437 2444
56. H.I. Yang, M.F. Yuen, H.L. Chan, K.H. Han, P.J. Chen, D.Y. Kim, and et al. Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score Lancet Oncol 12 2011 568 574
57. M.H. Lee, H.I. Yang, J. Liu, R. Batrla-Utermann, C.L. Jen, U.H. Iloeje, and et al. Prediction models of long-term cirrhosis and hepatocellular carcinoma risk in chronic hepatitis B patients: risk scores integrating host and virus profiles Hepatology 58 2013 546 554
58. R.J. Clifford, J. Zhang, D.M. Meerzaman, M.S. Lyu, Y. Hu, C.M. Cultraro, and et al. Genetic variations at loci involved in the immune response are risk factors for hepatocellular carcinoma Hepatology 52 2010 2034 2043
59. H. Zhang, Y. Zhai, Z. Hu, C. Wu, J. Qian, W. Jia, and et al. Genome-wide association study identifies 1p36.22 as a new susceptibility locus for hepatocellular carcinoma in chronic hepatitis B virus carriers Nat Genet 42 2010 755 758
60. D.K. Jiang, J. Sun, G. Cao, Y. Liu, D. Lin, Y.Z. Gao, and et al. Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus-related hepatocellular carcinoma Nat Genet 45 2013 72 75
61. J.C. Trinchet, C. Chaffaut, V. Bourcier, F. Degos, J. Henrion, H. Fontaine, and et al. Ultrasonographic surveillance of hepatocellular carcinoma in cirrhosis: a randomized trial comparing 3- and 6-month periodicities Hepatology 54 2011 1987 1997
62. V.W. Wong, G.L. Wong, A.M. Chim, P.C. Choi, A.W. Chan, S.W. Tsang, and et al. Surrogate end points and long-term outcome in patients with chronic hepatitis B Clin Gastroenterol Hepatol 7 2009 1113 1120
63. G.L. Wong, H.L. Chan, H.Y. Chan, P.C. Tse, Y.K. Tse, C.W. Mak, and et al. Accuracy of risk scores for patients with chronic hepatitis B receiving entecavir treatment Gastroenterology 144 2013 933 944
64. R. Zoutendijk, J.G. Reijnders, F. Zoulim, A. Brown, D.J. Mutimer, K. Deterding, and et al. Virological response to entecavir is associated with a better clinical outcome in chronic hepatitis B patients with cirrhosis Gut 62 2013 760 765
65. J.Y. Cho, Y.H. Paik, W. Sohn, H.C. Cho, G.Y. Gwak, M.S. Choi, and et al. Patients with chronic hepatitis B treated with oral antiviral therapy retain a higher risk for HCC compared with patients with inactive stage disease Gut 63 2014 1943 1950
66. H.L. Chan, C.K. Chan, A.J. Hui, S. Chan, F. Poordad, T.T. Chang, and et al. Effects of tenofovir disoproxil fumarate in hepatitis B e antigen-positive patients with normal levels of alanine aminotransferase and high levels of hepatitis B virus DNA Gastroenterology 146 2014 1240 1248
67. T.C. Tseng, C.J. Liu, C.L. Chen, H.C. Yang, T.H. Su, C.C. Wang, and et al. Risk stratification of hepatocellular carcinoma in hepatitis B virus e antigen-negative carriers by combining viral biomarkers J Infect Dis 208 2013 584 593
68. P. Arends, M.J. Sonneveld, R. Zoutendijk, I. Carey, A. Brown, M. Fasano, and et al. Entecavir treatment does not eliminate the risk of hepatocellular carcinoma in chronic hepatitis B: limited role for risk scores in Caucasians Gut 2014 10.1136/gutjnl-2014-307023 [Epub ahead of print]
69. G.V. Papatheodoridis, G.N. Dalekos, C. Yurdaydin, M. Buti, J. Goulis, P. Arends, and et al. Incidence and predictors of hepatocellular carcinoma in Caucasian chronic hepatitis B patients receiving entecavir or tenofovir J Hepatol 62 2015 363 370
70. G.V. Papatheodoridis, G.N. Dalekos, V. Sypsa, C. Yurdaydin, M. Buti, J. Goulis, and et al. PAGE-B: risk score for hepatocellular carcinoma (HCC) development in Caucasian chronic hepatitis B (CHB) patients receiving entecavir (ETV) or tenofovir (TDF) J Hepatol 60 2014 S435
71. A.S. Lok, and B.J. McMahon Chronic hepatitis B: update 2009 Hepatology 50 2009 661 662
72. European Association for the Study of the Liver EASL clinical practice guidelines: management of chronic hepatitis B virus infection J Hepatol 57 2012 167 185
73. Y.F. Liaw, J.H. Kao, T. Piratvisuth, H.L. Chan, R.N. Chien, C.J. Liu, and et al. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update Hepatol Int 6 2012 531 561
74. V.W. Wong, and H.L. Chan Transient elastography J Gastroenterol Hepatol 25 2010 1726 1731
75. G.L. Wong, V.W. Wong, P.C. Choi, A.W. Chan, R.H. Chum, H.K. Chan, and et al. Assessment of fibrosis by transient elastography compared with liver biopsy and morphometry in chronic liver diseases Clin Gastroenterol Hepatol 6 2008 1027 1035
76. H.L. Chan, G.L. Wong, P.C. Choi, A.W. Chan, A.M. Chim, K.K. Yiu, and et al. Alanine aminotransferase-based algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B J Viral Hepat 16 2009 36 44
77. P. Marcellin, M. Ziol, P. Bedossa, C. Douvin, R. Poupon, V. de Ledinghen, and et al. Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B Liver Int 29 2009 242 247
78. K.S. Jung, S.U. Kim, S.H. Ahn, Y.N. Park, Y. Kim do, J.Y. Park, and et al. Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using liver stiffness measurement (FibroScan) Hepatology 53 2011 885 894
79. G.L. Wong, H.L. Chan, C.K. Wong, C. Leung, C.Y. Chan, P.P. Ho, and et al. Liver stiffness-based optimization of hepatocellular carcinoma risk score in patients with chronic hepatitis B J Hepatol 60 2014 339 345
80. Y. Kim do, K.J. Song, S.U. Kim, E.J. Yoo, J.Y. Park, S.H. Ahn, and et al. Transient elastography-based risk estimation of hepatitis B virus-related occurrence of hepatocellular carcinoma: development and validation of a predictive model Onco Targets Ther 6 2013 1463 1469
81. G.L. Wong, V.W. Wong, P.C. Choi, A.W. Chan, A.M. Chim, K.K. Yiu, and et al. Increased liver stiffness measurement by transient elastography in severe acute exacerbation of chronic hepatitis B J Gastroenterol Hepatol 24 2009 1002 1007
82. V.W. Wong, P. Lampertico, V. deLedinghen, P.E. Chang, S.U. Kim, Y. Chen, and et al. Probability-based interpretation of liver stiffness measurement in untreated chronic hepatitis B patients Dig Dis Sci 60 2015 1448 1456
83. G. Millonig, S. Friedrich, S. Adolf, H. Fonouni, M. Golriz, A. Mehrabi, and et al. Liver stiffness is directly influenced by central venous pressure J Hepatol 52 2010 206 210
84. G. Millonig, F.M. Reimann, S. Friedrich, H. Fonouni, A. Mehrabi, M.W. Buchler, and et al. Extrahepatic cholestasis increases liver stiffness (FibroScan) irrespective of fibrosis Hepatology 48 2008 1718 1723
85. I. Mederacke, K. Wursthorn, J. Kirschner, K. Rifai, M.P. Manns, H. Wedemeyer, and et al. Food intake increases liver stiffness in patients with chronic or resolved hepatitis C virus infection Liver Int 29 2009 1500 1506
86. G.L. Wong, V.W. Wong, P.C. Choi, A.W. Chan, A.M. Chim, K.K. Yiu, and et al. On-treatment monitoring of liver fibrosis with transient elastography in chronic hepatitis B patients Antivir Ther 16 2011 165 172
87. D. Zhang, M. Chen, R. Wang, Y. Liu, D. Zhang, L. Liu, and et al. Comparison of acoustic radiation force impulse imaging and transient elastography for non-invasive assessment of liver fibrosis in patients with chronic hepatitis B Ultrasound Med Biol 41 2015 7 14
88. V.Y. Leung, J. Shen, V.W. Wong, J. Abrigo, G.L. Wong, A.M. Chim, and et al. Quantitative elastography of liver fibrosis and spleen stiffness in chronic hepatitis B carriers: comparison of shear-wave elastography and transient elastography with liver biopsy correlation Radiology 269 2013 910 918
89. Y. Shi, Q. Guo, F. Xia, B. Dzyubak, K.J. Glaser, Q. Li, and et al. MR elastography for the assessment of hepatic fibrosis in patients with chronic hepatitis B infection: does histologic necroinflammation influence the measurement of hepatic stiffness? Radiology 273 2014 88 98
90. A.Y. Hui, H.L. Chan, V.W. Wong, C.T. Liew, A.M. Chim, F.K. Chan, and et al. Identification of chronic hepatitis B patients without significant liver fibrosis by a simple noninvasive predictive model Am J Gastroenterol 100 2005 616 623
91. G.L. Wong, V.W. Wong, P.C. Choi, A.W. Chan, and H.L. Chan Development of a non-invasive algorithm with transient elastography (Fibroscan) and serum test formula for advanced liver fibrosis in chronic hepatitis B Aliment Pharmacol Ther 31 2010 1095 1103
92. T. Poynard, F. Zoulim, V. Ratziu, F. Degos, F. Imbert-Bismut, P. Deny, and et al. Longitudinal assessment of histology surrogate markers (FibroTest-ActiTest) during lamivudine therapy in patients with chronic hepatitis B infection Am J Gastroenterol 100 2005 1970 1980
93. G.L. Wong, H.L. Chan, P.C. Choi, A.W. Chan, Z. Yu, J.W. Lai, and et al. Non-invasive algorithm of enhanced liver fibrosis and liver stiffness measurement with transient elastography for advanced liver fibrosis in chronic hepatitis B Aliment Pharmacol Ther 39 2014 197 208
94. B.K. Kim, H.S. Kim, E.J. Yoo, E.J. Oh, J.Y. Park, Y. Kim do, and et al. Risk assessment of clinical outcomes in Asian patients with chronic hepatitis B using enhanced liver fibrosis test Hepatology 60 2014 1911 1919
95. R. Chaiteerakij, B.D. Addissie, and L.R. Roberts Update on biomarkers of hepatocellular carcinoma Clin Gastroenterol Hepatol 13 2015 237 245
96. P.J. Johnson, S.J. Pirrie, T.F. Cox, S. Berhane, M. Teng, D. Palmer, and et al. The detection of hepatocellular carcinoma using a prospectively developed and validated model based on serological biomarkers Cancer Epidemiol Biomarkers Prev 23 2014 144 153
97. N.C. Yu, V. Chaudhari, S.S. Raman, C. Lassman, M.J. Tong, R.W. Busuttil, and et al. CT and MRI improve detection of hepatocellular carcinoma, compared with ultrasound alone, in patients with cirrhosis Clin Gastroenterol Hepatol 9 2011 161 167